Application of biological optimization of hypofractionated radiotherapy post conservative surgery fo

来源 :肿瘤学与转化医学(英文) | 被引量 : 0次 | 上传用户:mywindjs
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective The aim of the study was to discuss the application of biological optimization and its difference from physical optimization in hypofractionated radiotherapy for breast cancer after conservative surgery. Methods This retrospective study enrolled 15 randomly chosen patients with left-sided breast cancer who received radiotherapy. The volumetric arc therapy (VMAT) technique was used to redesign treatment plans with physical functions (PF) group, biological-physical functions combined (BF + PF and PF + BF) groups, and biological functions (BF) group. The dosimetric differences based on the above four optimization methods were assessed by calculating and analyzing the corresponding dose-volume parameters.Results The target parameters of the four groups differed significantly (P < 0.05) except for the conformity index (CI). The tumor control probability (TCP) values in the BF and BF + PF groups were higher than those in the PF and PF + BF groups. Moreover, the dose-volume parameters of the ipsilateral lung in the BF group were less than those of three other groups, while the monitor unit (MU) in the BF group was approximately 16% lower than those of the PF and PF + BF groups. Conclusion Biological functions were useful to increase the equivalent uniform dose (EUD) and TCP values of the target, decrease the dose-volume parameters of the organs-at-risk (OARs), and improve treatment efficiency.
其他文献
期刊
【目的和意义】造血干细胞移植(Hematopoietic Stem Cell Transplantation, HSCT)是目前治疗恶性血液病的最有效方法之一,供者和患者人类白细胞抗原系统(Human Leukocyte Ant
期刊
期刊
Acute promyelocytic leukemia(APL)is a distinct type of acute leukemia. At present,all-trans retinoic acid(ATRA)-arsenic is the first-line treatment in APL patie
Objective This study aimed to assess anxiety, depression, and stress among inpatients with cancer. Methods Two hundred thirty-five hospitalized patients with ca